Galnon

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Relapse represents one of the most significant problems in the long-term treatment of drug addiction. Cocaine blocks plasma… (More)
Is this relevant?
2014
2014
OBJECTIVES Previous studies have shown galanin (GAL) injections onto mouse calvaria increased bone thickness and osteoblast… (More)
Is this relevant?
2008
2008
The mechanisms underlying responses to drugs of abuse have been widely investigated; however, less is known about pathways… (More)
  • figure 1
  • figure 3
  • figure 2
  • figure 5
  • figure 4
Is this relevant?
2007
2007
Galanin's influence on monoaminergic neurotransmission, together with its discrete CNS distribution in corticolimbic brain areas… (More)
Is this relevant?
2005
2005
Galnon was first reported as a low molecular weight non-peptide agonist at galanin receptors [Saar et al. (2002) Proc. Natl. Acad… (More)
Is this relevant?
2005
2005
Galanin is a neurotransmitter peptide that suppresses insulin secretion. The present study aimed at investigating how a non… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Review
2005
Review
2005
Galnon is a low-molecular weight galanin receptor ligand, with affinity towards the three galanin receptors in the micromolar… (More)
Is this relevant?
2004
2004
Galanin is a neuropeptide that has been implicated in multiple bioactivities, inter alia eating disorders. In this study, we have… (More)
Is this relevant?
2003
2003
We have examined the effect of systemically administered galnon, a novel low-molecular weight agonist of galanin receptors, on… (More)
Is this relevant?
2002
2002
Galanin is a neuropeptide with a wide variety of biological functions, including that of a strong endogenous anticonvulsant. No… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?